Track the Kato (Hong Kong) Holdings Ltd. stock price and the full directors' dealings record of the company, a publicly traded company based in Hong Kong. Shares are quoted on the HK market, under the supervision of HKEX. Operating in the Health Care sector, Kato (Hong Kong) Holdings Ltd. has recorded 11 public disclosures. Market capitalisation: €480m. The latest transaction was filed on 14 August 2026 (Purchase). Among the most active insiders: Ngai Shi Shing Godfrey. The full history is openly available.
11
Insider Decl.
n/a
Thresholds
€257,058
11 ops.
Buy Volume
n/a
n/a
Sell Volume
18Σ signal
Buys €257,058n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 6,144 of 29,062 companies
66.1
score / 100
Value
73
Quality
60
FCF yld14%
Earn yld4.4%
EV/EBITDA8.5x
ROE7.5%
Gross mgn94%
Net mgn6.9%
Debt/EBITDA3.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
156,000 shares@ HK$0.4450.0016% mcap3.9% of flowShareXHKGHKEX:DA20260320E00376
11 of 11 declarations
About Kato (Hong Kong) Holdings Ltd.
Kato (Hong Kong) Holdings Ltd. is a company operating in the healthcare and pharmaceutical sector. It is listed on the Hong Kong Stock Exchange under the symbol XHKG.